The effect of surgeon volume on procedure selection in non-small cell lung cancer surgeries. Dr. Christian Finley MD MPH FRCSC McMaster University

Similar documents
Supplementary Online Content

Estimates and predictors of health care costs of esophageal adenocarcinoma: a population-based cohort study

ORIGINAL PAPER. Marginal pulmonary function is associated with poor short- and long-term outcomes in lung cancer surgery

Complex Thoracoscopic Resections for Locally Advanced Lung Cancer

Measure #164 (NQF 0129): Coronary Artery Bypass Graft (CABG): Prolonged Intubation National Quality Strategy Domain: Effective Clinical Care

Zhao Y Y et al. Ann Intern Med 2012;156:

AHA Clinical Science Special Report: November 10, 2015

Patient and Hospital Characteristics Associated with Nephron-Sparing Surgery for Small, Localized Kidney Cancers in California,

Thoracoscopic Lobectomy: Technical Aspects in Years of Progress

Research and Innovation in Aging Forum December 15, 2015

Postoperative Mortality in Lung Cancer Patients

Comprehensive Research Plan: Inhaled corticosteroids + long-acting beta agonists (ICS+LABA) for the treatment of asthma

Indications for sublobar resection for localized NSCLC

Recent evidence regarding resection rate, specialism and survival in lung cancer in the UK

Ethnic Disparities in the Treatment of Stage I Non-small Cell Lung Cancer. Juan P. Wisnivesky, MD, MPH, Thomas McGinn, MD, MPH, Claudia Henschke, PhD,

Predictors of Palliative Therapy Receipt in Stage IV Colorectal Cancer

Dr. Thomas D Amico serves as a consultant for Scanlan. The other authors have no conflicts of interest to report.

Rayzel Shulman MD, PhD CAHSPR May 10, 2016

Thoracoscopic Lobectomy for Locally Advanced Lung Cancer. Masters of Minimally Invasive Thoracic Surgery Orlando September 19, 2014

Proper Treatment Selection May Improve Survival in Patients With Clinical Early-Stage Nonsmall Cell Lung Cancer

Region of Waterloo Public Health and Emergency Services Infectious Diseases, Dental, and Sexual Health

The Influence of Surgeon Specialty on Outcomes in General Thoracic Surgery: A National Sample 1996 to 2005

T3 NSCLC: Chest Wall, Diaphragm, Mediastinum

Association Between Surgeon and Hospital Volume and In-Hospital Fatalities After Lung Cancer Resections: The Experience of an Asian Country

STS General Thoracic Surgery Database (GTSD) Update

After primary tumor treatment, 30% of patients with malignant

Best Practices for Fast Track in Bariatric Surgery: Enhanced Recovery After Bariatric Surgery

L ung cancer takes more lives than any other cancer in the

Quality metrics for resection: Are they reasonable?

Intraoperative Oncologic Staging and Outcomes for Lung Cancer Resection Vary by Surgeon Specialty

Interest in minimally invasive surgical interventions, Impact of Hospital Volume of Thoracoscopic Lobectomy on Primary Lung Cancer Outcomes

Lung cancer is a major cause of cancer deaths worldwide.

The right middle lobe is the smallest lobe in the lung, and

Supplementary Online Content

FEV1 predicts length of stay and in-hospital mortality in patients undergoing cardiac surgery

National Bowel Cancer Audit Supplementary Report 2011

Racial and Socioeconomic Disparities in Appendicitis

The prevalence of type 2 diabetes mellitus is increasing CMAJ OPEN. Research

Surgical Outcomes: A synopsis & commentary on the Cardiac Care Quality Indicators Report. May 2018

Appendix 1 (as supplied by the authors): Databases and definitions used.

Leah M Smith, Jay S Kaufman, Erin C Strumpf, Linda E Lévesque

In 2015, Cleveland Clinic surgeons performed 1551 thoracic procedures. The in-hospital mortality rate was 2.1%. 20% airway (N = 315)

Supplemental materials for:

Treatment disparities for patients diagnosed with metastatic bladder cancer in California

Project Cohort EXPOSED GROUP

CIHI s Population Grouping Methodology: Beyond Predicting Costs

Pulmonary resection remains the most effective. Survival in Synchronous vs Single Lung Cancer. Upstaging Better Reflects Prognosis

Ankle fractures are one of

The impact of certification of general thoracic surgeons on lung cancer mortality: a survey by The Japanese Association for Thoracic Surgery

Person-years; number of study participants (number of cases) HR (95% CI) P for trend

Inequity in access to guideline-recommended colorectal cancer treatment in Nova Scotia, Canada

Supplementary Online Content

Recognition of Complications After Pancreaticoduodenectomy for Cancer Determines Inpatient Mortality

Weekend Admission and In- Hospital Mortality: Should Patients Avoid Hospitals on Weekends? Canadian Institute for Health Information (CIHI)

The Society of Thoracic Surgeons General Thoracic Surgery Database: Establishing Generalizability to National Lung Cancer Resection Outcomes

Prolonged air leak after video-assisted thoracic surgery lung cancer resection: risk factors and its effect on postoperative clinical recovery

Effect of Insurance Status on the Surgical Treatment of Early-Stage Non-Small Cell Lung Cancer

Lung Cancer in Octogenarians: Factors Affecting Morbidity and Mortality After Pulmonary Resection

Cardiovascular. Mathew Mercuri PhD(C), Sonia S Anand MD PhD FRCP(C)

UNIVERSITY OF CALGARY. diabetes mellitus. Vinay Deved A THESIS SUBMITTED TO THE FACULTY OF GRADUATE STUDIES

A DISSERTATION SUBMITTED TO THE FACULTY OF THE GRADUATE SCHOOL OF THE UNIVERSITY OF MINNESOTA BY. Helen Mari Parsons

Patterns and Cost of Health Care Transitions to Adult Care among Youth with Chronic Conditions in Ontario: A Population Based Cohort Study

Comparison of Medicare Fee-for-Service Beneficiaries Treated in Ambulatory Surgical Centers and Hospital Outpatient Departments

Major Infection After Pediatric Cardiac Surgery: External Validation of Risk Estimation Model

Quality ID#164 (NQF 0129): Coronary Artery Bypass Graft (CABG): Prolonged Intubation National Quality Strategy Domain: Effective Clincial Care

On-going and planned colorectal cancer clinical outcome analyses

Superior and Basal Segment Lung Cancers in the Lower Lobe Have Different Lymph Node Metastatic Pathways and Prognosis

Does Volume in a Pediatric Cardiac Surgery Program Impact the Results?

Identifying Geographic & Socioeconomic Disparities in Access to Care for Pediatric Cancer Patients in Texas

Exposure to potentially inappropriate medications among long-term care residents with cognitive impairment in Ontario:

ACOSOG Thoracic Committee. Kemp H. Kernstine, MD PhD

Identifying and evaluating patterns of prescription opioid use and associated risks in Ontario, Canada Gomes, T.

Transfusion & Mortality. Philippe Van der Linden MD, PhD

Ninety-day mortality after resection for lung cancer is nearly double 30-day mortality

ACOSOG (NCCTG, CALGB) Alliance Thoracic Committee Kemp H. Kernstine, MD PhD

Trends in Glucocorticoid-Induced Osteoporosis Management Among Seniors in Ontario,

Visceral pleural involvement (VPI) of lung cancer has

The Impact of Adjuvant Chemotherapy in Pulmonary Large Cell Neuroendocrine Carcinoma (LCNC)

Defining High Users in Acute Care: An Examination of Different Approaches. Better data. Better decisions. Healthier Canadians.

Total and attributable healthcare costs of hypertension: Historic and projected costs in Alberta, Canada

Comparative Study on Three Algorithms of the ICD-10 Charlson Comorbidity Index with Myocardial Infarction Patients

Treatment of Clinical Stage I Lung Cancer: Thoracoscopic Lobectomy is the Standard

Prognostic Factors for Survival of Stage IB Upper Lobe Non-small Cell Lung Cancer Patients: A Retrospective Study in Shanghai, China

Lung cancer is one of the most common and most. Delays in the Diagnosis and Treatment of Lung Cancer*

Association of a Modified Frailty Index with Postoperative Outcomes after Ankle Fractures in Patients Aged 55 and Older

Predicting Short Term Morbidity following Revision Hip and Knee Arthroplasty

Impact of Hospital Volume on Chest Tube Duration, Length of Stay, and Mortality After Lobectomy

Pulmonary laser resections: Technical aspects and results in colorectal cancer

Emergency Department Visits With Facial Fractures Among Children and Adolescents: An Analysis of Profile and Predictors of Causes of Injuries

Lungebevarende resektioner ved lungecancer metode og resultater

Tristate Lung Meeting 2014 Pro-Con Debate: Surgery has no role in the management of certain subsets of N2 disease

Outcomes of Patients with Preoperative Weight Loss following Colorectal Surgery

Measuring the risk in valve patients Lessons learnt from the TAVI story? Bernard Iung Bichat Hospital, Paris, France

The Pennsylvania State University. The Graduate School. College of Medicine. The Department of Public Health Sciences

Modeling major lung resection outcomes using classification trees and multiple imputation techniques

The Effect of Patient Neighbourhood Income Level on the Purchase of Continuous Positive Airway

Multi-institutional Evaluation of Adherence to Comprehensive Postoperative Venous Thromboembolism Chemoprophylaxis

Demand and Burden of Dental Care in Canadian Households. Mustafa Andkhoie, MPH PhD student, Epidemiology University of Saskatchewan May 27 th, 2015

Transcription:

The effect of surgeon volume on procedure selection in non-small cell lung cancer surgeries Dr. Christian Finley MD MPH FRCSC McMaster University

Disclosures I have no conflict of interest disclosures to report

Background Ginsburg et al. Modern thirty-day operative mortality for surgical resections in lung cancer. J Thorac Cardiovasc Surg. 1983 Nov;86(5):654-8. Pneumonectomy Mortality = 6.2% Lobectomy Mortality = 2.9% 25% Pneumonectomy rate

Background Harpole et al. Prognostic models of thirty-day mortality and morbidity after major pulmonary resection. J Thorac Cardiovasc Surg. 1999 May;117(5):969-79. Pneumonectomy Mortality = 11.5% Lobectomy Mortality = 4.0% 18% Pneumonectomy rate

Background Pneumonectomy: the burden of death after discharge and predictors of surgical mortality Ann Thorac Surg. 2014 Dec;98(6):1976-81; discussion 1981-2. The burden of death following discharge after lobectomy. Eur J Cardiothorac Surg. 2014 Nov 24. Pneumonectomy Mortality = 4.4% 90 day = 10.8% Lobectomy Mortality = 1.4% 90 day = 3.3%

Decision making Large geographical variation in the surgical resection rate for NSCLC 3-18% A high frequency of resection was strongly inversely associated with overall mortality HR 0.88, 95% CI 0.86-0.91 Moderately associated with mortality amongst the resected patients HR 1.15, 95% CI 0.98-1.36 5420 deaths could be avoided whereas about 146 more deaths could be expected amongst the resected patients Riaz et al. Eur J Cancer. 2012 Jan;48(1):54-60

Objective This study aims to examine surgeon choices for non-small cell lung cancer (NSCLC) and if surgeon volume predicts the type of procedure chosen Controlling for patient demographics, comorbidity, year of surgery and institutional factors

Methods The dataset was constructed from the population-based linked databases accessed via the Institute for Clinical Evaluate Sciences Ontario Cancer Registry Ontario Health Insurance Plan claims Canadian Institutes for Health Information Discharge Abstract Database (CIHI-DAD) National Ambulatory Care Reporting Service database (NACRS)

Methods Population: All pulmonary resections for primary NSCLC Time period: 2004 2011 De-identified information collected on: Patient Factors Gender, age, income quintile, location of residence (rural vs. urban), comorbidity Procedural details Year of procedure, institution volume, surgeon volume Outcomes Length of stay, in-hospital mortality and 90-day postdischarge mortality

Outcomes Analysis Multilevel logistic regression analyses were performed to examine factors that influence a surgeon s choice of surgery A three-level random effects model was used to control for the cluster effect of physician nested within institution Ninety-day mortality for each procedure was calculated

Outcomes Analysis Stage Data Due to limited availability, stage data could not be included as a predictor variable in the regression model Accurate stage data was available for the only the last two years of study, 2010 and 2011 These were added to the multilevel regression model in order to examine trends that could be attributed to stage of disease

Results 8070 patients that underwent surgical resection for NSCLC, of whom 4070 (50.4%) were male 124 unique physicians and 45 institutions Distribution of resection types: Pneumonectomy: 842 (10.4%) Fell from 14.8% to 7.6% from 2004 to 2011 Lobectomy: 6212 (77.0%) Wedge resection 1002 (12.4%) 12.1% to 10.7% from 2004 to 2011

Results Average 90-day mortality: Pneumonectomy = 12.6% Lobectomy = 3.9% 2.6% in 2011 Wedge resection = 5.7% 2.8% in 2011

Multivariate Model Physician volume, age, year of procedure, gender, and Charlson Comorbidity Index were all predictive of selecting pneumonectomy as choice of surgery After adjusting for all other variables, the results indicated that for each additional 10 unit increase in physician volume, the risk of performing a pneumonectomy decreases by 9.1% (95% CI=8.2 to 10.0, p=0.04)

Conclusion While patient and temporal factors influence the type of resection a patient receives for NSCLC, surgeon volume is also a strong predictor This study may be limited by minimal stage data, but the suggestion that a surgeon s total procedural volume for NSCLC significantly influences procedure selection has implications on how we deliver care to this patient population